The genome backgrounds of multiple myeloma (MM) would affect the efficacy of specific treatment. However, the mutational and transcriptional...

Multiple Myeloma (MM) is the most common primary osseous malignancy in adults, and it mainly affects men aged between 50 and 70 years. Although rare...

Abstract Background Over the last decade there has been considerable research into the treatment, management, and quality of life of people living...

Abstract Background Most patients with multiple myeloma (MM) relapse or become refractory, resulting in high health care costs. However, real world...

Multiple myeloma (MM) is a hematologic malignancy characterized by the clonal proliferation of plasma cells in the bone marrow with a median age at...

Abstract Introduction Angiogenesis is considered important in the pathogenesis of multiple myeloma (MM), as well as in the targeted treatment of the...

Abstract Purpose A diagnostic model to differentiate multiple myeloma (MM) from bone metastasis (BM) in patients with destructive bone lesions (MM BM...

Abstract Objectives Multiple myeloma (MM) is a malignant disease characterized by a single clonal proliferation of B cell derived plasma cells in the...

Abstract Background Spinal metastasis and multiple myeloma share many overlapping conventional radiographic imaging characteristics, thus, their...

Multiple myeloma (MM) is a neoplasia of B plasma cells that often induces bone pain. However, the mechanisms underlying myeloma induced bone pain...

Multiple myeloma (MM) is a common hematologic malignancy that remains incurable. Although accumulating evidence suggests that the leucine rich repeat...

Abstract Background There is growing evidence that conversations between healthcare professionals and patients with serious illness can improve the...